The launch supports Baxter’s ongoing efforts to expand its anti-infective portfolio to increase access to essential medications and advance patient care.
The joint development and commercialization agreement will initially focus on the development of a bioprinting solution for CollPlant’s regenerative breast implants.
Baxter unveiled multiple new additions to its surgical portfolios at the AORN Global Surgical Conference & Expo 2023, taking place April 1 through April 4, 2023.
Sean Fitall, Positronic Product Manager at PEI-Genesis, discusses the versatility of D-Sub connectors and why they are the best connector for many challenging applications.